ConductScience.org, home

Library / Trials

An Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults

NCT02446314, Not applicable, Completed, University of Reading; results first posted 2019-08-08

Trial 11

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleAn Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older AdultsClinicalTrials.gov
NCT numberNCT02446314ClinicalTrials.gov
StatusCompletedClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment122 participants, actualClinicalTrials.gov
Lead sponsorUniversity of ReadingClinicalTrials.gov
ConditionsCognitive DeclineClinicalTrials.gov
InterventionsPlacebo, Wild Blueberry Powder - 450mg, Wild Blueberry Powder - 900 mg, Wild Blueberry extract 100mgClinicalTrials.gov
First posted2015-05-18ClinicalTrials.gov
Last updated2019-08-08ClinicalTrials.gov
Results first posted2019-08-08ClinicalTrials.gov

Registered outcomes 10

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryProportion of Words Correctly Recognised.12, and 24 weeksParticipants indicate whether words presented on a monitor are from a list of 15 words previously presented auditorily (via headphones), or if they are novel foils.ClinicalTrials.gov
PrimaryTotal Number of Correct Sequences Recalled12, and 24 weeksParticipants view an array of 9 white squares on a monitor which light up red in sequences of between 2 and 9. They are then required to press the correct squares in the sequence they were presented.ClinicalTrials.gov
PrimaryCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.12, and 24 weeks
Combined Z score of proportion of words recalled, proportion of words recognised, and proportion of pictures recognised. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome
ClinicalTrials.gov
SecondaryCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.12, and 24 weeks
Combined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome.
ClinicalTrials.gov
SecondaryCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line12, and 24 weeks
Combined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, and the Coefficient of the Line for Reaction Time by Length of Sting During Probe Recall. The Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean. Negative numbers indicate values lower than the mean and positive numbers indicate values higher than the mean. A negative change value reflects a decrease in memory or a worse outcome and a positive change value reflects an increase in memory or a better outcome
ClinicalTrials.gov
SecondarySystolic Blood Pressure12, and 24 weeks.LMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.ClinicalTrials.gov
SecondaryDiastolic Blood Pressure12, and 24 weeksLMM analysis of intervention group x 12 and 24 wk test session. Baseline blood pressure entered as a covariate.ClinicalTrials.gov
SecondaryHeart Rate12, and 24 weeks.LMM analysis of intervention group x 12 and 24 wk test session. Baseline heart rate entered as a covariate.ClinicalTrials.gov
SecondaryPositive Affect Score12, and 24 weeks
As measured by the positive mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to positive affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher positive affect.
ClinicalTrials.gov
SecondaryNegative Affect Score12, and 24 weeks.
As measured by the negative mood scale derived from the Positive and Negative Affect Schedule. This measure consists of 10 words relating to negative affect. The participants is asked to rate how they feel about each word from 1 (very slightly/not at all) to 5 (extremely) with a minimum score of 5 and maximum of 50. A higher score relates to higher negative affect.
ClinicalTrials.gov

Outcomes 10

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource
PRIMARYProportion of Words Correctly Recognised.12, and 24 weeksproportion of words correctly recognisedMEANClinicalTrials.gov
PRIMARYTotal Number of Correct Sequences Recalled12, and 24 weeksCorrect number of sequencesMEANClinicalTrials.gov
PRIMARYCombined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.12, and 24 weeksz-scoreMEANClinicalTrials.gov
SECONDARYCombined Z Score of Mean Reaction Time Scores for Incongruent Attention Network and Stroop Task Trials.12, and 24 weeksz-scoreMEANClinicalTrials.gov
SECONDARYCombined Z Score of Proportion of Immediate Words Recalled, Number of Correct Serial 3 and Serial 7 Subtractions, Sternberg Task Coefficent of the Line12, and 24 weeksz-scoreMEANClinicalTrials.gov
SECONDARYSystolic Blood Pressure12, and 24 weeks.mmHgMEANClinicalTrials.gov
SECONDARYDiastolic Blood Pressure12, and 24 weeksmmHgMEANClinicalTrials.gov
SECONDARYHeart Rate12, and 24 weeks.beats/minMEANClinicalTrials.gov
SECONDARYPositive Affect Score12, and 24 weeksunits on a scaleMEANClinicalTrials.gov
SECONDARYNegative Affect Score12, and 24 weeks.units on a scaleMEANClinicalTrials.gov

Results by group 80

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource
Proportion of Words Correctly Recognised.Placebo12 Weeks0.86Standard Error 0.02proportion of words correctly recognisedClinicalTrials.gov
Proportion of Words Correctly Recognised.Wild Blueberry Powder - 450mg12 Weeks0.85Standard Error 0.02proportion of words correctly recognisedClinicalTrials.gov
Proportion of Words Correctly Recognised.Wild Blueberry Powder - 900 mg12 Weeks0.79Standard Error 0.02proportion of words correctly recognisedClinicalTrials.gov
Proportion of Words Correctly Recognised.Wild Blueberry Extract 100mg12 Weeks0.90Standard Error 0.02proportion of words correctly recognisedClinicalTrials.gov
Proportion of Words Correctly Recognised.Placebo24 Weeks0.90Standard Error 0.02proportion of words correctly recognisedClinicalTrials.gov
Proportion of Words Correctly Recognised.Wild Blueberry Powder - 450mg24 Weeks0.88Standard Error 0.02proportion of words correctly recognisedClinicalTrials.gov
Proportion of Words Correctly Recognised.Wild Blueberry Powder - 900 mg24 Weeks0.87Standard Error 0.02proportion of words correctly recognisedClinicalTrials.gov
Proportion of Words Correctly Recognised.Wild Blueberry Extract 100mg24 Weeks0.88Standard Error 0.02proportion of words correctly recognisedClinicalTrials.gov
Total Number of Correct Sequences RecalledPlacebo12 Weeks15.15Standard Error 0.41Correct number of sequencesClinicalTrials.gov
Total Number of Correct Sequences RecalledWild Blueberry Powder - 450mg12 Weeks14.27Standard Error 0.40Correct number of sequencesClinicalTrials.gov
Total Number of Correct Sequences RecalledWild Blueberry Powder - 900 mg12 Weeks15.42Standard Error 0.39Correct number of sequencesClinicalTrials.gov
Total Number of Correct Sequences RecalledWild Blueberry Extract 100mg12 Weeks16.19Standard Error 0.39Correct number of sequencesClinicalTrials.gov
Total Number of Correct Sequences RecalledPlacebo24 Weeks15.56Standard Error 0.48Correct number of sequencesClinicalTrials.gov
Total Number of Correct Sequences RecalledWild Blueberry Powder - 450mg24 Weeks16.348Standard Error 0.47Correct number of sequencesClinicalTrials.gov
Total Number of Correct Sequences RecalledWild Blueberry Powder - 900 mg24 Weeks15.921Standard Error 0.46Correct number of sequencesClinicalTrials.gov
Total Number of Correct Sequences RecalledWild Blueberry Extract 100mg24 Weeks16.302Standard Error 0.46Correct number of sequencesClinicalTrials.gov
Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.Placebo12 Weeks0.19Standard Error 0.11z-scoreClinicalTrials.gov
Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.Wild Blueberry Powder - 450mg12 Weeks0.08Standard Error 0.11z-scoreClinicalTrials.gov
Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.Wild Blueberry Powder - 900 mg12 Weeks0.02Standard Error 0.11z-scoreClinicalTrials.gov
Combined Z Score of Delayed Words Recalled, Words Recognised, and Pictures Recognised.Wild Blueberry Extract 100mg12 Weeks0.28Standard Error 0.11z-scoreClinicalTrials.gov

Participant flow 24

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource
Zero to Twelve Weeks.STARTEDPlacebo30ClinicalTrials.gov
Zero to Twelve Weeks.STARTEDWild Blueberry Powder - 450mg30ClinicalTrials.gov
Zero to Twelve Weeks.STARTEDWild Blueberry Powder - 900 mg31ClinicalTrials.gov
Zero to Twelve Weeks.STARTEDWild Blueberry Extract 100mg31ClinicalTrials.gov
Zero to Twelve Weeks.COMPLETEDPlacebo27ClinicalTrials.gov
Zero to Twelve Weeks.COMPLETEDWild Blueberry Powder - 450mg29ClinicalTrials.gov
Zero to Twelve Weeks.COMPLETEDWild Blueberry Powder - 900 mg31ClinicalTrials.gov
Zero to Twelve Weeks.COMPLETEDWild Blueberry Extract 100mg29ClinicalTrials.gov
Zero to Twelve Weeks.NOT COMPLETEDPlacebo3ClinicalTrials.gov
Zero to Twelve Weeks.NOT COMPLETEDWild Blueberry Powder - 450mg1ClinicalTrials.gov
Zero to Twelve Weeks.NOT COMPLETEDWild Blueberry Powder - 900 mg0ClinicalTrials.gov
Zero to Twelve Weeks.NOT COMPLETEDWild Blueberry Extract 100mg2ClinicalTrials.gov
Thirteen to Twenty Four WeeksSTARTEDPlacebo27ClinicalTrials.gov
Thirteen to Twenty Four WeeksSTARTEDWild Blueberry Powder - 450mg29ClinicalTrials.gov
Thirteen to Twenty Four WeeksSTARTEDWild Blueberry Powder - 900 mg31ClinicalTrials.gov
Thirteen to Twenty Four WeeksSTARTEDWild Blueberry Extract 100mg29ClinicalTrials.gov
Thirteen to Twenty Four WeeksCOMPLETEDPlacebo27ClinicalTrials.gov
Thirteen to Twenty Four WeeksCOMPLETEDWild Blueberry Powder - 450mg28ClinicalTrials.gov
Thirteen to Twenty Four WeeksCOMPLETEDWild Blueberry Powder - 900 mg29ClinicalTrials.gov
Thirteen to Twenty Four WeeksCOMPLETEDWild Blueberry Extract 100mg28ClinicalTrials.gov

Adverse events 4

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource
otherDiarrhoea / Looser StoolGastrointestinal disordersPlacebo130ClinicalTrials.gov
otherDiarrhoea / Looser StoolGastrointestinal disordersWild Blueberry Powder - 500mg030ClinicalTrials.gov
otherDiarrhoea / Looser StoolGastrointestinal disordersWild Blueberry Powder - 1000 mg131ClinicalTrials.gov
otherDiarrhoea / Looser StoolGastrointestinal disordersWild Blueberry Extract 111mg231ClinicalTrials.gov

Adverse event totals 12

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource
Total, all-cause mortalityPlacebo030ClinicalTrials.gov
Total, all-cause mortalityWild Blueberry Powder - 500mg030ClinicalTrials.gov
Total, all-cause mortalityWild Blueberry Powder - 1000 mg031ClinicalTrials.gov
Total, all-cause mortalityWild Blueberry Extract 111mg031ClinicalTrials.gov
Total, other adverse eventsPlacebo130ClinicalTrials.gov
Total, other adverse eventsWild Blueberry Powder - 500mg030ClinicalTrials.gov
Total, other adverse eventsWild Blueberry Powder - 1000 mg131ClinicalTrials.gov
Total, other adverse eventsWild Blueberry Extract 111mg231ClinicalTrials.gov
Total, serious adverse eventsPlacebo030ClinicalTrials.gov
Total, serious adverse eventsWild Blueberry Powder - 500mg030ClinicalTrials.gov
Total, serious adverse eventsWild Blueberry Powder - 1000 mg031ClinicalTrials.gov
Total, serious adverse eventsWild Blueberry Extract 111mg031ClinicalTrials.gov

Papers 5

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
19680703BACKGROUNDPubMed
20047325BACKGROUNDPubMed
22569815BACKGROUNDPubMed
23723987BACKGROUNDPubMed
29882843RESULTPubMed

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 2

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource
Sternberg Memory ScanningSecondary outcomeConductCognition
Stroop Color-Word TestSecondary outcomeConductCognition

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)